Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. The University of Oxford and The Department of Chemistry are Silver Athena SWAN holders. Applications are particularly welcome from women and black and ethnic minority candidates, who are under-represented in
-
selection criteria, please click on the link below. The closing date for applications is 12.00 midday, 14 May 2024. Interviews will be held as soon as possible thereafter. The University of Oxford and The
-
the Department of Psychiatry, University of Oxford. The post is for a fixed term (funded for 24 months). OHBA is part of the Wellcome centre for Integrative Neuroimaging (WIN) at the University of Oxford
-
materials, including catalysts. This is an exciting and challenging role which will contribute to the development of open source software. All applications must be made online using the Oxford University E
-
modelling of magnetic systems using computational tools. All applications must be made online using the Oxford University E-Recruitment system, no later than 12 noon on 24 May 2024. You will be required
-
have submitted their final PhD thesis at the point of interview and are awaiting final examination are eligible to apply for this role. How to apply The University of Oxford is committed to equality and
-
. The postholder will work in the group of Simon Myers (University of Oxford), which works broadly on statistical genetics, and genomics, including of variants impacting human phenotypes and their evolution. This is
-
for Sports Medicine and Technology at the University of Oxford. This full-time post is fixed-term for 24 months, with the possibility of an extension. The Postdoctoral Researcher will work under the
-
to Dr Jani R Bolla. The work is to be conducted in his lab in the Department Biology, University of Oxford, South Parks Road, Oxford, OX1 3RB. The postholder will support ongoing research that aims
-
are invited in any of the four Oxford BHF CRE research themes. The proposed research project will be hosted by a cardiovascular research group at the University of Oxford, and should be developed in liaison